Mohammed A. Assiri , Faris Almutairi , Abdullah Alsulais , Mohammed F. Alhamdan , Omar A. Almohammed , Fawaz Alasmari , Nouf Albishi , Ali Aghamdi , Lamia AlMuhareb , Rana AlMotawa , Sara Alrasheed , Feras S. Aldawsari , Saud T. Aloyayd , Abdullah A. Alhejji , Abdulrazaq Albilali , Riham A.ElToukhy , Ghada A. Aldrees , Doaa A. Bintaleb , Hicham Benabdelkamel , Assim A. Alfadda , Sary Alsanea
{"title":"Paracetamol exposure induces rapid alterations in the human plasma proteome","authors":"Mohammed A. Assiri , Faris Almutairi , Abdullah Alsulais , Mohammed F. Alhamdan , Omar A. Almohammed , Fawaz Alasmari , Nouf Albishi , Ali Aghamdi , Lamia AlMuhareb , Rana AlMotawa , Sara Alrasheed , Feras S. Aldawsari , Saud T. Aloyayd , Abdullah A. Alhejji , Abdulrazaq Albilali , Riham A.ElToukhy , Ghada A. Aldrees , Doaa A. Bintaleb , Hicham Benabdelkamel , Assim A. Alfadda , Sary Alsanea","doi":"10.1016/j.taap.2025.117501","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Paracetamol is a widely used analgesic and antipyretic, yet its effect on human plasma proteome remains poorly characterized. This study aims to evaluate the impact of a single therapeutic dose of paracetamol on the plasma proteome, potentially providing insights into its pharmacological and toxicological pathways.</div></div><div><h3>Methods</h3><div>We conducted a cross-sectional study with 28 age-matched fasting subjects (14 controls and 14 treated with paracetamol). Anthropometric measurements and laboratory parameters were assessed, and blood samples were collected. An untargeted label-free LC-MS/MS approach, bioinformatics, and network pathway analysis were employed to examine changes in the proteomic profile.</div></div><div><h3>Results</h3><div>Proteomic analyses revealed significant differences in plasma protein abundance between the groups. A total of 78 dysregulated proteins were identified, with 23 upregulated and 55 downregulated in the paracetamol group. Transthyretin and vascular cell adhesion protein 1 were upregulated, while doublecortin domain-containing protein 1 and alpha-1-acid glycoprotein 1 were downregulated. These proteins were associated with key pathways, including ligand binding, Fc gamma receptor-dependent phagocytosis, and IL-12 signaling.</div></div><div><h3>Conclusion</h3><div>This proteomic analysis lays the groundwork for further studies to elucidate the mechanisms underlying paracetamol's therapeutic and toxicological effects by highlighting significant dysregulated proteins and related pathways.</div></div>","PeriodicalId":23174,"journal":{"name":"Toxicology and applied pharmacology","volume":"504 ","pages":"Article 117501"},"PeriodicalIF":3.4000,"publicationDate":"2025-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Toxicology and applied pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0041008X25002777","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Paracetamol is a widely used analgesic and antipyretic, yet its effect on human plasma proteome remains poorly characterized. This study aims to evaluate the impact of a single therapeutic dose of paracetamol on the plasma proteome, potentially providing insights into its pharmacological and toxicological pathways.
Methods
We conducted a cross-sectional study with 28 age-matched fasting subjects (14 controls and 14 treated with paracetamol). Anthropometric measurements and laboratory parameters were assessed, and blood samples were collected. An untargeted label-free LC-MS/MS approach, bioinformatics, and network pathway analysis were employed to examine changes in the proteomic profile.
Results
Proteomic analyses revealed significant differences in plasma protein abundance between the groups. A total of 78 dysregulated proteins were identified, with 23 upregulated and 55 downregulated in the paracetamol group. Transthyretin and vascular cell adhesion protein 1 were upregulated, while doublecortin domain-containing protein 1 and alpha-1-acid glycoprotein 1 were downregulated. These proteins were associated with key pathways, including ligand binding, Fc gamma receptor-dependent phagocytosis, and IL-12 signaling.
Conclusion
This proteomic analysis lays the groundwork for further studies to elucidate the mechanisms underlying paracetamol's therapeutic and toxicological effects by highlighting significant dysregulated proteins and related pathways.
期刊介绍:
Toxicology and Applied Pharmacology publishes original scientific research of relevance to animals or humans pertaining to the action of chemicals, drugs, or chemically-defined natural products.
Regular articles address mechanistic approaches to physiological, pharmacologic, biochemical, cellular, or molecular understanding of toxicologic/pathologic lesions and to methods used to describe these responses. Safety Science articles address outstanding state-of-the-art preclinical and human translational characterization of drug and chemical safety employing cutting-edge science. Highly significant Regulatory Safety Science articles will also be considered in this category. Papers concerned with alternatives to the use of experimental animals are encouraged.
Short articles report on high impact studies of broad interest to readers of TAAP that would benefit from rapid publication. These articles should contain no more than a combined total of four figures and tables. Authors should include in their cover letter the justification for consideration of their manuscript as a short article.